Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Tech

Kontrol Technologies expands use of its BioCLoud technology for HVAC and building systems

Under non-disclosure agreements, the company is supplying three additional organizations with BioCloud patents, testing, data, and analytics

Kontrol Technologies Corp (OTCQB:KNRLF, NEO:KNR), a leader in smart buildings and cities through IoT, Cloud, and SaaS technology, is expanding the use of its BioCLoud technology.

In a statement, the company said it has provided a use-case update for HVAC (heating, ventilation, and air conditioning) and buildings, as well as growing demand for data and analytics for BioCloud under three non-disclosure agreements (NDAs).

"BioCloud’s positive recent in-field performance provided additional technology validation which has resulted in immediate interest from organizations seeking innovative solutions to monitor and improve air quality,” said Kontrol CEO Paul Ghezzi.

READ: Kontrol Technologies raises full-year 2022 revenue guidance after seeing increased demand for its BioCloud units

Chezzi added: “Under non-disclosure agreements, we are supplying three additional organizations with BioCloud technology patents, testing, data and analytics. We are executing well on our strategy to grow our presence in regional markets by building relationships with large organizations which have a scalable business model. By employing a data-driven approach, we are continuously adding to our solution value proposition through technology enhancements, while substantiating key use cases for integration with buildings and HVAC systems.”

Kontrol said all organizations under the NDAs currently offer a myriad of viral and pathogen testing solutions and air quality technology and are interested in BioCloud as a potential integrated solution to create safer spaces.

For example, one of the organizations operates as a global conglomerate in facility testing, certification, and benchmarking, with about $7 billion in annual revenues.

“While there is no certainty that the execution of an NDA and the sharing of all technical data will result in revenues related to the NDA, the Company is pleased by its recent in-field testing results and will announce progress on potential distribution agreements or strategic partnerships as they are executed,” Kontrol said.

Reducing airborne exposure

Kontrol noted that, according to the American Society of Heating, Refrigerating and Air-Conditioning Engineers or (ASHRAE), the transmission of SARS-CoV-2 (COVID-19) through the air is significant and should be controlled. Changes to building operations, including the operation of HVAC systems, can reduce airborne exposures.

In the event of a virus or pathogen detection, Kontrol said more precise commands can be sent to the building automation systems for more ventilation and fresh air exchange over a specific period of time.

The company said this additional intelligence is tied to BioCloud’s ability to integrate with buildings’ automation systems in real-time.

“BioCloud can serve as an important technology integration into the majority of HVAC systems as well as a stand-alone solution in an office setting or spaces where individuals gather,” Kontrol added.

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK